Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype

[1]  R. Eeles,et al.  Genome-wide association studies in cancer. , 2008, Human molecular genetics.

[2]  J. Rioux,et al.  Autoimmune diseases: insights from genome-wide association studies. , 2008, Human molecular genetics.

[3]  Cornelia M van Duijn,et al.  Genome-based prediction of common diseases: advances and prospects. , 2008, Human molecular genetics.

[4]  G. Abecasis,et al.  Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants. , 2008, Human molecular genetics.

[5]  M. Esteller,et al.  Epigenetic biomarkers for human cancer: the time is now. , 2008, Critical reviews in oncology/hematology.

[6]  T. Schultheiss.  The radiation dose-response of the human spinal cord. , 2008, International journal of radiation oncology, biology, physics.

[7]  Li Ma,et al.  Parallel and serial computing tools for testing single-locus and epistatic SNP effects of quantitative traits in genome-wide association studies , 2008, BMC Bioinformatics.

[8]  B. Ponder,et al.  Polygenes, risk prediction, and targeted prevention of breast cancer. , 2008, The New England journal of medicine.

[9]  Philippe Froguel,et al.  Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. , 2008, Human molecular genetics.

[10]  Philippe Froguel,et al.  Common genetic variation near MC4R is associated with waist circumference and insulin resistance , 2008, Nature Genetics.

[11]  David A. Scott,et al.  Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment , 2008, British Journal of Cancer.

[12]  C. Gieger,et al.  Identification of ten loci associated with height highlights new biological pathways in human growth , 2008, Nature Genetics.

[13]  Sara M Weis,et al.  Vascular permeability in cardiovascular disease and cancer , 2008, Current opinion in hematology.

[14]  Matthew E Hurles,et al.  The functional impact of structural variation in humans. , 2008, Trends in genetics : TIG.

[15]  Christophe Badie,et al.  Evidence for significant heritability of apoptotic and cell cycle responses to ionising radiation , 2008, Human Genetics.

[16]  Marco Foiani,et al.  Regulation of DNA repair throughout the cell cycle , 2008, Nature Reviews Molecular Cell Biology.

[17]  J. Yarnold,et al.  The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet. Oncology.

[18]  J. Overgaard,et al.  Genetic markers for prediction of normal tissue toxicity after radiotherapy. , 2008, Seminars in radiation oncology.

[19]  J R Yarnold,et al.  The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet.

[20]  Rebecca C Taylor,et al.  Apoptosis: controlled demolition at the cellular level , 2008, Nature Reviews Molecular Cell Biology.

[21]  Trevor Hastie,et al.  Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  Ali Amin Al Olama,et al.  Multiple newly identified loci associated with prostate cancer susceptibility , 2008, Nature Genetics.

[23]  D. Strachan,et al.  LDL-cholesterol concentrations: a genome-wide association study , 2008, The Lancet.

[24]  D. Lawlor,et al.  Common variants in the GDF5-UQCC region are associated with variation in human height , 2008, Nature Genetics.

[25]  P. Elliott,et al.  Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides , 2008, Nature Genetics.

[26]  Peter M Visscher,et al.  Genome-wide association studies of quantitative traits with related individuals: little (power) lost but much to be gained , 2008, European Journal of Human Genetics.

[27]  T. Ogihara,et al.  High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project. , 2007, Human molecular genetics.

[28]  Oliver Sieber,et al.  A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk , 2007, Nature Genetics.

[29]  J D Pickard,et al.  Early radiotherapy dose response and lack of hypersensitivity effect in normal brain tissue: a sequential dynamic susceptibility imaging study of cerebral perfusion. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[30]  Marcel van Herk,et al.  Different styles of image-guided radiotherapy. , 2007 .

[31]  Daniel Levy,et al.  Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness , 2007, BMC Medical Genetics.

[32]  R. D'Agostino,et al.  A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study , 2007, BMC Medical Genetics.

[33]  X. Estivill,et al.  Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability , 2007, Nature Reviews Genetics.

[34]  N G Burnet,et al.  The genomics revolution and radiotherapy. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[35]  Oliver Sieber,et al.  A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 , 2007, Nature Genetics.

[36]  G. Thomas,et al.  Heritability of susceptibility to ionizing radiation-induced apoptosis of human lymphocyte subpopulations. , 2007, International journal of radiation oncology, biology, physics.

[37]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[38]  P. Donnelly,et al.  Replicating genotype–phenotype associations , 2007, Nature.

[39]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[40]  Marcia M. Nizzari,et al.  Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.

[41]  James Strait,et al.  Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits , 2007, PLoS genetics.

[42]  F. Stewart,et al.  Gene expression arrays as a tool to unravel mechanisms of normal tissue radiation injury and prediction of response. , 2007, World journal of gastroenterology.

[43]  A. Busjahn,et al.  Genetic determination of chromosomal radiosensitivities in G0- and G2-phase human lymphocytes. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  M. Ramoni,et al.  Gene expression changes in peripheral blood cells provide insight into the biological mechanisms associated with regimen-related toxicities in patients being treated for head and neck cancers. , 2007, Oral oncology.

[45]  M. Plumb,et al.  The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes , 2007, British Journal of Cancer.

[46]  R. Redon,et al.  Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes , 2007, Science.

[47]  C. Caldas,et al.  Pharmacogenetics of cancer chemotherapy. , 2006, Biochimica et biophysica acta.

[48]  Michael B Sharpe,et al.  Image-guided radiotherapy: rationale, benefits, and limitations. , 2006, The Lancet. Oncology.

[49]  R. T. Ten Haken,et al.  The clinical application of intensity-modulated radiation therapy. , 2006, Seminars in radiation oncology.

[50]  Harry Vrieling,et al.  Analysis of Gene Expression Using Gene Sets Discriminates Cancer Patients with and without Late Radiation Toxicity , 2006, PLoS medicine.

[51]  M. Munafo,et al.  The endophenotype concept in psychiatric genetics , 2006, Psychological Medicine.

[52]  K. Ang,et al.  Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis , 2006, The Lancet.

[53]  S. Bentzen.  Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology , 2006, Nature Reviews Cancer.

[54]  N G Burnet,et al.  Radiosensitivity, radiogenomics and RAPPER. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[55]  M. Spitz,et al.  Mutagen sensitivity has high heritability: evidence from a twin study. , 2006, Cancer research.

[56]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[57]  Christopher U. Jones,et al.  Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.

[58]  Michael Baumann,et al.  Influence of connective tissue diseases on the expression of radiation side effects: a systematic review. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[59]  F. B. Sørensen,et al.  Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATMndash; a study based on DNA from formalin fixed paraffin embedded tissue samples , 2006, International journal of radiation biology.

[60]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[61]  R. Mirimanoff,et al.  CD4 and CD8 T-Lymphocyte Apoptosis Can Predict Radiation-Induced Late Toxicity: A Prospective Study in 399 Patients , 2005, Clinical Cancer Research.

[62]  J. Olsen,et al.  G2 chromosomal radiosensitivity in Danish survivors of childhood and adolescent cancer and their offspring , 2005, British Journal of Cancer.

[63]  D. Duggan,et al.  Recent developments in genomewide association scans: a workshop summary and review. , 2005, American journal of human genetics.

[64]  W A Tomé,et al.  Intensity-modulated radiation therapy: emerging cancer treatment technology , 2005, British Journal of Cancer.

[65]  J. Yarnold,et al.  TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[66]  C. Andreassen.  Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? , 2005, Acta oncologica.

[67]  D. Scott,et al.  Chromosomal radiosensitivity and low penetrance predisposition to cancer , 2004, Cytogenetic and Genome Research.

[68]  M. Mckay,et al.  Clinical and cellular radiosensitivity in inherited human syndromes. , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

[69]  R. Tibshirani,et al.  Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Søren M Bentzen,et al.  High-tech in radiation oncology: should there be a ceiling? , 2004, International journal of radiation oncology, biology, physics.

[71]  J. Overgaard,et al.  Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[72]  Michael Baumann,et al.  Towards genetic prediction of radiation responses: ESTRO's GENEPI project. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[73]  R. Mikkelsen,et al.  Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms , 2003, Oncogene.

[74]  J. Petrini,et al.  The cellular response to DNA double-strand breaks: defining the sensors and mediators. , 2003, Trends in cell biology.

[75]  J. Peacock,et al.  Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. , 2003, International journal of radiation oncology, biology, physics.

[76]  C. Sabatti,et al.  The Human Phenome Project , 2003, Nature Genetics.

[77]  Bengt Brorsson,et al.  The Swedish Council on Technology Assessment in Health Care (SBU) Systematic Overview of Radiotherapy for Cancer including a Prospective Survey of Radiotherapy Practice in Sweden 2001--Summary and Conclusions , 2003, Acta oncologica.

[78]  A. Hajeer,et al.  Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients , 2003, International journal of radiation biology.

[79]  H. Suit,et al.  The Gray Lecture 2001: coming technical advances in radiation oncology. , 2002, International journal of radiation oncology, biology, physics.

[80]  E. Glatstein.  Intensity-modulated radiation therapy: the inverse, the converse, and the perverse. , 2002, Seminars in radiation oncology.

[81]  B. Alter.  Radiosensitivity in Fanconi's anemia patients. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[82]  C. West,et al.  Relationship between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiation reactions: a comparison of training and validation cohorts of breast cancer patients. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[83]  C. West,et al.  Differential Expression of Cytokine Genes in Fibroblasts Derived from Skin Biopsies of Patients who Developed Minimal or Severe Normal Tissue Damage after Radiotherapy , 2002, Radiation research.

[84]  R. Cowan,et al.  Short report: a morbidity scoring system for Clinical Oncology practice: questionnaires produced from the LENT SOMA scoring system. , 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

[85]  S. Roberts,et al.  Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix. , 2001, International journal of radiation oncology, biology, physics.

[86]  C. Arlett,et al.  Four radiation hypersensitivity cases and their implications for clinical radiotherapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[87]  K. Trott,et al.  Volume effects in radiobiology as applied to radiotherapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[88]  J. Yarnold,et al.  Cellular radiosensitivity and complication risk after curative radiotherapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[89]  D. Evans,et al.  Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? , 1999, American journal of human genetics.

[90]  J. Peacock,et al.  Describing patients' normal tissue reactions: Concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity , 1998, International journal of cancer.

[91]  R H Brook,et al.  The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. , 1998, Medical care.

[92]  A. Hart,et al.  Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer. , 1998, International journal of radiation biology.

[93]  J H Hendry,et al.  The intrinsic radiosensitivity of normal and tumour cells. , 1998, International journal of radiation biology.

[94]  J Nyman,et al.  Prognostic factors for acute and late skin reactions in radiotherapy patients. , 1996, International Journal of Radiation Oncology, Biology, Physics.

[95]  S M Bentzen,et al.  Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[96]  F. Collins,et al.  The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. , 1995, Human molecular genetics.

[97]  C. West,et al.  Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy. , 1995, The British journal of radiology.

[98]  J. Overgaard,et al.  Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now! , 1995, International journal of radiation oncology, biology, physics.

[99]  H. Withers,et al.  Complicating issues in complication reporting. , 1995, International journal of radiation oncology, biology, physics.

[100]  J. Yarnold,et al.  The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules , 1994 .

[101]  T. Pajak,et al.  Analysis of the probability and risk of cause-specific failure. , 1994, International journal of radiation oncology, biology, physics.

[102]  C. Haie-meder,et al.  Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. , 1994, International journal of radiation oncology, biology, physics.

[103]  Bentzen,et al.  Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury. , 1994, Seminars in radiation oncology.

[104]  J. Horiot,et al.  A glossary for reporting complications of treatment in gynecological cancers. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[105]  S Schraub,et al.  Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[106]  R. Wurm,et al.  Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity , 1992, The Lancet.

[107]  S. Bentzen,et al.  Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[108]  I. Turesson.  Individual variation and dose dependency in the progression rate of skin telangiectasia. , 1990, International journal of radiation oncology, biology, physics.

[109]  A Brahme,et al.  Optimization of uncomplicated control for head and neck tumors. , 1990, International journal of radiation oncology, biology, physics.

[110]  A. Hinney,et al.  An instance of clinical radiation morbidity and cellular radiosensitivity, not associated with ataxia-telangiectasia. , 1990, The British journal of radiology.

[111]  J. Little,et al.  Sensitivity of human diploid fibroblast cell strains from various genetic disorders to acute and protracted radiation exposure. , 1990, Radiation research.

[112]  J. Little,et al.  In vitro radiosensitivity of human diploid fibroblasts derived from women with unusually sensitive clinical responses to definitive radiation therapy for breast cancer. , 1990, Radiation research.

[113]  H D Thames,et al.  Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[114]  W. Woods,et al.  Sensitivity of cultured cells to gamma radiation in a patient exhibiting marked in vivo radiation sensitivity , 1988, Cancer.

[115]  B. Kimler,et al.  Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia. , 1986, International journal of radiation oncology, biology, physics.

[116]  A. Taylor,et al.  Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity , 1975, Nature.

[117]  R Paterson,et al.  Radiotherapy for Cancer* , 1939, British medical journal.

[118]  D. Diz,et al.  Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. , 2006, International journal of radiation oncology, biology, physics.

[119]  Penny A. Jeggo,et al.  The role of double-strand break repair — insights from human genetics , 2006, Nature Reviews Genetics.

[120]  T. Lawrence,et al.  Radiotherapy: what can be achieved by technical improvements in dose delivery? , 2005, The Lancet. Oncology.

[121]  J. Denekamp,et al.  Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. , 2000, International journal of radiation oncology, biology, physics.

[122]  D. Postma,et al.  Genetics of allergic disease. , 2000, British medical bulletin.

[123]  R. Wurm,et al.  Normal tissue radiosensitivity--how important is it? , 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

[124]  W A Brock,et al.  Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. , 1993, International journal of radiation oncology, biology, physics.

[125]  J. Overgaard,et al.  Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. , 1993, European journal of cancer.

[126]  D. Levy,et al.  Bmc Medical Genetics Genome-wide Association Study of Electrocardiographic and Heart Rate Variability Traits: the Framingham Heart Study on Behalf of the Framingham Heart Study 100k Cardiovascular Disease Working Group , 2022 .

[127]  P. Munroe,et al.  Genome-wide association analysis identifies 20 loci that influence adult height , 2008, Nature Genetics.

[128]  M. Jarvelin,et al.  References and Notes Supporting Online Material Materials and Methods Som Text Figs. S1 to S7 References a Common Variant in the Fto Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2022 .